{"id":4463,"date":"2025-09-09T18:11:34","date_gmt":"2025-09-09T15:11:34","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4463"},"modified":"2025-09-09T18:11:35","modified_gmt":"2025-09-09T15:11:35","slug":"belief-biomed-announced-successful-completion-of-first-dose-of-bbm-d101-gene-therapy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/belief-biomed-announced-successful-completion-of-first-dose-of-bbm-d101-gene-therapy\/","title":{"rendered":"Belief BioMed a annonc\u00e9 la r\u00e9ussite de la premi\u00e8re dose de th\u00e9rapie g\u00e9nique BBM-D101"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Belief BioMed, une soci\u00e9t\u00e9 de biotechnologie innovante ax\u00e9e sur le d\u00e9veloppement de th\u00e9rapies g\u00e9niques de pointe, a annonc\u00e9 aujourd&#039;hui que l&#039;essai clinique d&#039;enregistrement (CTR20252461) de son injection BBM-D101 d\u00e9velopp\u00e9e et produite ind\u00e9pendamment pour la dystrophie musculaire de Duchenne (DMD) a termin\u00e9 avec succ\u00e8s le premier dosage sur un patient \u00e0 P\u00e9kin, en Chine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L&#039;injection de BBM-D101, une th\u00e9rapie g\u00e9nique bas\u00e9e sur un AAV, utilise une capside modifi\u00e9e pour cibler efficacement les tissus musculaires. Administr\u00e9e \u00e0 une dose inf\u00e9rieure \u00e0 celle de ses homologues commercialis\u00e9s \u00e0 l&#039;\u00e9tranger, elle devrait offrir une s\u00e9curit\u00e9 favorable. L&#039;IND pour BBM-D101 a \u00e9t\u00e9 approuv\u00e9e par la National Medical Products Administration (NMPA) de Chine et la Food and Drug Administration (FDA) des \u00c9tats-Unis en 2025.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Apprendre encore plus<\/strong>: <a href=\"https:\/\/dmdwarrior.com\/fr\/belief-biomed-bbm-d101-gene-therapy-phase-1-2-clinical-trial-nct07058662\/\" target=\"_blank\" rel=\"noreferrer noopener\">D\u00e9but de l&#039;essai clinique de phase 1\/2 de la th\u00e9rapie g\u00e9nique BBM-D101<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Belief BioMed, an innovative biotechnology company focused on developing cutting-edge gene therapies, today announced that the registration clinical trial (CTR20252461) of its independently developed and produced BBM-D101 injection for Duchenne Muscular Dystrophy (DMD) has successfully completed the first patient dosing in Beijing, China. BBM-D101 injection, an AAV-based gene therapy, utilizes an engineered capsid to efficiently [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4464,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[199,197,123,137,242,61],"class_list":["post-4463","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-bbm-d101","tag-belief-biomed","tag-china","tag-clinical-trial","tag-clinical-trials","tag-gene-therapy"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/4463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=4463"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/4463\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/4464"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=4463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=4463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=4463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}